Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Aug 15, 2024; 16(8): 3559-3584
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3559
Published online Aug 15, 2024. doi: 10.4251/wjgo.v16.i8.3559
Table 2 Risk factors for prognosis in patients with gastric cancer
| Variable | Univariate analysis, HR (95%CI) | P value | Multivariate analysis, HR (95%CI) | P value |
| CASC19 | 5.986 (2.854-12.555) | < 0.001 | 2.478 (1.071-5.736) | 0.034 |
| Gender | 1.056 (0.544-2.048) | 0.872 | ||
| Age | 1.407 (0.756-2.619) | 0.282 | ||
| Differentiation grade | 0.965 (0.471-1.976) | 0.922 | ||
| Tumor size | 9.438 (4.397-20.257) | < 0.001 | 2.969 (1.189-7.415) | 0.02 |
| Tumor location | 0.736 (0.466-1.164) | 0.19 | ||
| TNM (I, II/III) | 10.293 (3.642-29.089) | < 0.001 | 4.122 (1.243-13.672) | 0.021 |
- Citation: Zhang LX, Luo PQ, Wei ZJ, Xu AM, Guo T. Expression and significant roles of the long non-coding RNA CASC19/miR-491-5p/HMGA2 axis in the development of gastric cancer. World J Gastrointest Oncol 2024; 16(8): 3559-3584
- URL: https://www.wjgnet.com/1948-5204/full/v16/i8/3559.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i8.3559